What is the current Prescription Headache Medicine market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Prescription Headache Medicine market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Prescription Headache Medicine market?

Increasing prevalence of headaches and rising demand for effective treatments drive the market.

What are the major challenges facing the Prescription Headache Medicine market?

Side effects and patent expirations of existing medications are significant challenges.

Which regions are the leaders in the Prescription Headache Medicine market?

North America and Europe are the leading regions due to high healthcare expenditures.

Who are the top companies in the Prescription Headache Medicine market?

Pfizer, GlaxoSmithKline, and Merck are among the top companies in the market.

What are the future opportunities in the Prescription Headache Medicine market?

Increasing demand for personalized medicine and growing investments in R&D offer future opportunities.

How does technology impact the Prescription Headache Medicine market?

Advances in digital healthcare and telemedicine improve patient outcomes and market growth.

What is the current regulatory landscape for the Prescription Headache Medicine market?

Stringent regulations and safety standards ensure the quality and efficacy of prescription headache medications.

What is the future outlook for the Prescription Headache Medicine market size?

The market size is expected to reach USD 1.8 billion by 2033 with a steady growth rate.

Prescription Headache Medicine Strategic Analysis & Growth Outlook 2033

Prescription Headache Medicine by Application (Hospital, Clinic, Drug Store), by Types (Sumatriptan, Rizatriptan, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $8.9 million

CAGR: 4.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $8.9 million

CAGR: 4.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Prescription Headache Medicine Market Size | CAGR 4.2 Forecast 2033

Prescription Headache Medicine Strategic Analysis & Growth Outlook 2033

🏭 Healthcare🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $8.9 million

CAGR: 4.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $8.9 million

CAGR: 4.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Prescription Headache Medicine Market Overview

The Prescription Headache Medicine market is a crucial segment of the pharmaceutical industry, providing relief to millions of people suffering from headaches worldwide. As the global population continues to urbanize and stress levels increase, the relevance of this market will only continue to grow. The Prescription Headache Medicine market size is estimated to be around $4.5 billion in 2025, with a growth outlook that is expected to drive the market forecast to reach $6.3 billion by 2033. This industry expansion is driven by factors such as an increasing prevalence of headaches, rising healthcare expenditure, and the introduction of new prescription medications. The scope of this market includes various types of prescription headache medicines, such as triptans, ergots, and pain relievers, which are used to treat different types of headaches, including migraines, tension headaches, and cluster headaches.

Loading chart…

The growth forecast for the Prescription Headache Medicine market is expected to be driven by a compound annual growth rate (CAGR) of 5.5% during the forecast period. Key forces shaping the industry include technology shifts towards more effective and targeted treatments, regulations that ensure the safety and efficacy of prescription medications, and consumer behavior that is increasingly health-conscious and proactive. The largest region for the Prescription Headache Medicine market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing healthcare expenditure and a growing middle class. Overall, the Prescription Headache Medicine market is expected to continue to grow and evolve in response to changing consumer needs and technological advancements.

Report Overview

Report Attribute	Details
Market size value in 2025	8.90 million
Revenue forecast in 2033	12.37 million
Growth rate	CAGR of 4.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GSK; Teva; Pfizer; Amgen; Viatris; Allergan; Grunenthal; Eli Lilly
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Prescription Headache Medicine market is poised for significant growth, driven by increasing demand for effective treatments and a rising prevalence of headache disorders. The market dynamics are influenced by various factors, including technological advancements, regulatory approvals, and shifting consumer preferences.

Growth Drivers2 items

Advances in medical technology, such as the development of new formulation types and administration routes, are expected to drive the Prescription Headache Medicine market size and contribute to its growth forecast.

The growing awareness of headache disorders and their impact on quality of life is leading to increased diagnosis and treatment rates, further fueling the demand for prescription headache medicines.

Restraints2 items

Stringent regulatory requirements and high research and development costs may hinder the growth of the Prescription Headache Medicine market, as companies may be deterred from investing in new product development.

The presence of generic and over-the-counter alternatives may also limit the market growth, as patients may opt for more affordable treatment options.

Opportunities2 items

The increasing focus on personalized medicine and targeted therapies presents opportunities for companies to develop innovative treatments and expand their presence in the Prescription Headache Medicine market.

The growing demand for prescription headache medicines in emerging economies, driven by rising healthcare expenditure and improving access to healthcare services, is expected to provide new growth avenues for market players.

Challenges2 items

The Prescription Headache Medicine market is highly competitive, with several established players and new entrants, making it challenging for companies to differentiate their products and maintain market share.

The need to balance pricing strategies with the pressure to reduce healthcare costs and improve patient access to affordable treatments may pose a significant challenge for companies operating in the market, affecting the overall growth forecast.

Market Segmentation

Loading chart…

The Prescription Headache Medicine market can be segmented based on Application, which includes the treatment of tension headaches, migraines, and cluster headaches. This segmentation contributes to the overall market size by highlighting the specific areas where prescription headache medicines are most effective, thus guiding pharmaceutical companies in their product development and marketing strategies. Understanding the Prescription Headache Medicine segmentation is crucial for industry players to tailor their offerings to meet the distinct needs of different patient groups.

Another key segmentation category in the Prescription Headache Medicine market is Types, which encompasses various subtypes such as triptans, ergots, and corticosteroids. Each subtype has its unique mechanism of action and is prescribed based on the severity and frequency of headaches. Analyzing these subtypes helps in determining their individual contributions to the overall market size, enabling companies to focus on research and development that addresses the most significant needs in the Prescription Headache Medicine market taxonomy.

Prescription Headache Medicine Segmentation Breakdown8 items

Application

Hospital

Clinic

Drug Store

Types

Sumatriptan

Rizatriptan

Others

Regional Insights

Loading chart…

The Prescription Headache Medicine market growth is anticipated to be driven by various factors across different regions. North America is the largest region, accounting for approximately 40% of the market share, driven by key drivers such as high adoption of prescription headache medicines, favorable policies supporting healthcare infrastructure, and substantial investments in research and development. Europe is the second-largest region, with a market share of around 30%, driven by mature ecosystem, high demographics of the aging population, and established infrastructure.

The fastest-growing region is expected to be Asia Pacific, with a regional forecast indicating a significant increase in market share, driven by growing demand for prescription headache medicines, increasing investments in healthcare infrastructure, and expanding demographics of the middle-class population. Latin America and Middle East & Africa are also expected to contribute to the Prescription Headache Medicine market growth, with market shares of around 15% and 15%, respectively, driven by rising adoption, government initiatives, and improving infrastructure.

Competitive Landscape

The Prescription Headache Medicine market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. The Prescription Headache Medicine competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to maintain their market position, while local companies emphasize regional expansion and cost advantages.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, and R&D investments. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To mitigate these risks, companies focus on technological advancements, service model optimization, and channel strength. The following companies have adopted distinct strategies:

GSK: regional expansion

Teva: vertical integration

Pfizer: premium pricing

Amgen: innovation pipeline

Viatris: local manufacturing

Allergan: OEM tie-ups

Key Prescription Headache Medicine Companies8 items

GSK

Teva

Pfizer

Amgen

Viatris

Allergan

Grunenthal

Eli Lilly

Market Ecosystem

The Prescription Headache Medicine ecosystem spans multiple stakeholders, from upstream technology providers and suppliers to downstream end users, with value created and captured at various stages. This ecosystem can be broadly divided into three segments: upstream, midstream, and downstream, with each segment playing a crucial role in the development, manufacturing, and distribution of prescription headache medicines. A comprehensive value chain analysis is essential to understand the complex interactions within the Prescription Headache Medicine ecosystem.

Raw material suppliers — providing active pharmaceutical ingredients

OEMs/manufacturers — producing prescription headache medicines

Technology providers — developing formulation and manufacturing technologies

System integrators — ensuring regulatory compliance and quality control

Distributors/channel partners — facilitating medicine distribution to pharmacies

Service providers — offering patient support and education services

Regulators/standards bodies — establishing and enforcing safety and efficacy standards

The flow of value within the Prescription Headache Medicine ecosystem is influenced by various control points, including regulatory approvals, manufacturing capacities, and distribution networks. Dependency risks arise from input constraints, such as the availability of active pharmaceutical ingredients, and standards, including those related to quality and safety. Switching costs and partnerships between ecosystem participants can also impact the ecosystem's functioning, with different regions having distinct characteristics that affect the Prescription Headache Medicine ecosystem.

Recent Industry Insights

The Prescription Headache Medicine industry has witnessed significant developments over the last 12-18 months, shaping the future of Prescription Headache Medicine industry trends. Recent partnerships have focused on advancing research and development of novel treatments, while mergers and acquisitions have led to consolidation and expansion of product portfolios. Notably, several companies have launched new products and technologies, including innovative formulations and delivery systems, to cater to the evolving needs of patients and healthcare providers.

Additionally, regulatory changes have influenced the industry landscape, with updates to labeling and packaging requirements aimed at enhancing patient safety and education. A shift in consumer trends towards personalized medicine and digital health has also been observed, driving demand for more targeted and technology-enabled solutions. Furthermore, funding rounds and expansions have enabled companies to invest in research and development, commercialization, and market outreach initiatives, ultimately contributing to the growth and evolution of the Prescription Headache Medicine market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Prescription Headache Medicine market outlook. The market attractiveness is moderate, driven by increasing demand for effective treatments and a growing patient population. Competitive intensity is high, with several key players competing for market share. The long-term outlook is positive, with opportunities for innovation and growth in emerging markets.

The innovation landscape is evolving, with a focus on personalized medicine and targeted therapies. Demand-supply balance is a key challenge, with fluctuations in supply chains and regulatory environments impacting market dynamics. Key risk factors include regulatory changes and patent expirations, which can significantly impact market players. Overall, the Prescription Headache Medicine market outlook is promising, with opportunities for growth and innovation in the coming years.

11 items

1. Executive Summary

2. Prescription Headache Medicine Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Prescription Headache Medicine Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Prescription Headache Medicine Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Drug Store

6.2. Global Prescription Headache Medicine Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Sumatriptan

6.2.2. Rizatriptan

6.2.3. Others

6.3. Global Prescription Headache Medicine Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Prescription Headache Medicine Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Prescription Headache Medicine Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Prescription Headache Medicine Market Competition by Key Manufacturers

8.1. Global Prescription Headache Medicine Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Prescription Headache Medicine: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. GSK

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Teva

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Pfizer

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Amgen

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Viatris

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Allergan

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Grunenthal

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Eli Lilly

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Prescription Headache Medicine Market

Figure 4: Global Prescription Headache Medicine Market: Drivers

Figure 5: Global Prescription Headache Medicine Market: Challenges

Figure 6: Global Prescription Headache Medicine Market: Trends

Figure 7: Global Prescription Headache Medicine Market: Opportunity

Figure 8: Global Prescription Headache Medicine Market: Restraint

Figure 9: Global Prescription Headache Medicine Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Prescription Headache Medicine Market Value (USD Million) By Region

Figure 15: Global Prescription Headache Medicine Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Prescription Headache Medicine Market Value (USD Million) By Region

Figure 23: Global Prescription Headache Medicine Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

69 items

Table 1: Market Segmentation Analysis

Table 2: Global Prescription Headache Medicine Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Prescription Headache Medicine Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Prescription Headache Medicine Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Prescription Headache Medicine Market Value (USD Million) By Region

Table 10: Global Prescription Headache Medicine Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Prescription Headache Medicine Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Prescription Headache Medicine Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Prescription Headache Medicine Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: GSK Basic Information And Sales Area

Table 31: GSK. Products Portfolio

Table 32: Teva Basic Information And Sales Area

Table 33: Teva. Products Portfolio

Table 34: Pfizer Basic Information And Sales Area

Table 35: Pfizer. Products Portfolio

Table 36: Amgen Basic Information And Sales Area

Table 37: Amgen. Products Portfolio

Table 38: Viatris Basic Information And Sales Area

Table 39: Viatris. Products Portfolio

Table 40: Allergan Basic Information And Sales Area

Table 41: Allergan. Products Portfolio

Table 42: Grunenthal Basic Information And Sales Area

Table 43: Grunenthal. Products Portfolio

Table 44: Eli Lilly Basic Information And Sales Area

Table 45: Eli Lilly. Products Portfolio

Table 46: Global Market Value (USD Million) (2025-2032) By Application

Table 47: Global Market Share (%) By Application (2032)

Table 48: Global Market Value (USD Million) (2025-2032) By Types

Table 49: Global Market Share (%) By Types (2032)

Table 50: Global Prescription Headache Medicine Market Value (USD Million) By Region

Table 51: Global Prescription Headache Medicine Market Share (%) By Region (2025-2032)

Table 52: North America Market Value (USD Million) (2025-2032) By Country

Table 53: North America Market Value (USD Million) (2025-2032) By Application

Table 54: North America Market Value (USD Million) (2025-2032) By Types

Table 55: Europe Market Value (USD Million) (2025-2032) By Country

Table 56: Europe Market Value (USD Million) (2025-2032) By Application

Table 57: Europe Market Value (USD Million) (2025-2032) By Types

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 59: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 61: South America Market Value (USD Million) (2025-2032) By Country

Table 62: South America Market Value (USD Million) (2025-2032) By Application

Table 63: South America Market Value (USD Million) (2025-2032) By Types

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 65: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 67: Research Programs/Design For This Report

Table 68: Key Data Information From Secondary Sources

Table 69: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Prescription Headache Medicine Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.90 million
Revenue forecast in 2033	12.37 million
Growth rate	CAGR of 4.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GSK; Teva; Pfizer; Amgen; Viatris; Allergan; Grunenthal; Eli Lilly
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options